Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Late fecal incontinence after high-dose radiotherapy for prostate cancer: better prediction using longitudinal definitions.
Fiorino C, Rancati T, Fellin G, Vavassori V, Cagna E, Casanova Borca V, Girelli G, Menegotti L, Monti AF, Tortoreto F, Delle Canne S, Valdagni R. Fiorino C, et al. Among authors: rancati t. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):38-45. doi: 10.1016/j.ijrobp.2011.06.1953. Epub 2011 Oct 8. Int J Radiat Oncol Biol Phys. 2012. PMID: 21985939
A joint physics and radiobiology DREAM team vision - Towards better response prediction models to advance radiotherapy.
Vens C, van Luijk P, Vogelius RI, El Naqa I, Humbert-Vidan L, von Neubeck C, Gomez-Roman N, Bahn E, Brualla L, Böhlen TT, Ecker S, Koch R, Handeland A, Pereira S, Possenti L, Rancati T, Todor D, Vanderstraeten B, Van Heerden M, Ullrich W, Jackson M, Alber M, Marignol L; ESTRO DREAM team. Vens C, et al. Among authors: rancati t. Radiother Oncol. 2024 Jul;196:110277. doi: 10.1016/j.radonc.2024.110277. Epub 2024 Apr 25. Radiother Oncol. 2024. PMID: 38670264 Free article. Review.
Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data: dosimetry, acute and two years physician and patient-reported outcomes.
Vakaet V, Deseyne P, Bultijnck R, Post G, West C, Azria D, Bourgier C, Farcy-Jacquet MP, Rosenstein B, Green S, de Ruysscher D, Sperk E, Veldwijk M, Herskind C, De Santis MC, Rancati T, Giandini T, Chang-Claude J, Seibold P, Lambrecht M, Weltens C, Janssens H, Vega A, Taboada-Valladares MB, Aguado-Barrera ME, Reyes V, Altabas M, Gutiérrez-Enríquez S, Monten C, Van Hulle H, Veldeman L. Vakaet V, et al. Among authors: rancati t. Acta Oncol. 2023 Sep;62(9):1036-1044. doi: 10.1080/0284186X.2023.2240486. Epub 2023 Aug 7. Acta Oncol. 2023. PMID: 37548182
Voxel-based analysis: Roadmap for clinical translation.
McWilliam A, Palma G, Abravan A, Acosta O, Appelt A, Aznar M, Monti S, Onjukka E, Panettieri V, Placidi L, Rancati T, Vasquez Osorio E, Witte M, Cella L. McWilliam A, et al. Among authors: rancati t. Radiother Oncol. 2023 Nov;188:109868. doi: 10.1016/j.radonc.2023.109868. Epub 2023 Sep 6. Radiother Oncol. 2023. PMID: 37683811 Free article. Review.
Association of radiation-induced normal tissue toxicity with a high genetic risk for rheumatoid arthritis.
Mcwilliam A, Marshall D, Kerns SL, Barnett GC, Vega A, Kapouranis T, Aguado Barrera ME, Avuzzi B, Azria D, Chang-Claude J, Choudhury A, Coedo Costa C, Dunning A, Farcy-Jacquet MP, Faivre-Finn C, Gutiérrez-Enríquez S, Fuentes Río O, Gómez Caamaño A, Lambrecht M, López Pleguezuelos C, Rancati T, Rattay T, De Ruysscher D, Seibold P, Sperk E, Talbot C, Webb A, Veldeman L, Rosenstein BS, West CML; REQUITE Consortium. Mcwilliam A, et al. Among authors: rancati t. J Natl Cancer Inst. 2025 Jan 6:djae349. doi: 10.1093/jnci/djae349. Online ahead of print. J Natl Cancer Inst. 2025. PMID: 39761002
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.
Jandu HK, Veal CD, Fachal L, Luccarini C, Aguado-Barrera ME, Altabas M, Azria D, Baten A, Bourgier C, Bultijnck R, Colciago RR, Farcy-Jacquet MP, Chang-Claude J, Choudhury A, Dunning A, Elliott RM, Green S, Gutiérrez-Enríquez S, Herskind C, Lambrecht M, Monten C, Rancati T, Reyes V, Rosenstein BS, De Ruysscher D, Carmen De Santis M, Seibold P, Sperk E, Veldwijk M, Paul Symonds R, Stobart H, Taboada-Valladares B, Vega A, Veldeman L, Webb AJ, Weltens C, West CM, Rattay T, Talbot CJ; REQUITE consortium. Jandu HK, et al. Among authors: rancati t. Radiother Oncol. 2023 Oct;187:109806. doi: 10.1016/j.radonc.2023.109806. Epub 2023 Jul 10. Radiother Oncol. 2023. PMID: 37437607 Free article.
Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study.
Vavassori V, Fiorino C, Rancati T, Magli A, Fellin G, Baccolini M, Bianchi C, Cagna E, Mauro FA, Monti AF, Munoz F, Stasi M, Franzone P, Valdagni R. Vavassori V, et al. Among authors: rancati t. Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1401-10. doi: 10.1016/j.ijrobp.2006.10.040. Epub 2007 Jan 22. Int J Radiat Oncol Biol Phys. 2007. PMID: 17241754
164 results